Related Experiment Video
Updated: Jul 18, 2026

In Vitro Differentiation of Human CD4+FOXP3+ Induced Regulatory T Cells (iTregs) from Naïve CD4+ T Cells Using a TGF-β-containing Protocol
Published on: December 30, 2016
Immunosuppressive activity of recombinant ILT3
George Vlad1, Zhuoru Liu, Qing-Yin Zhang
1Department of Pathology, Columbia University, 630 West 168th Street, P and S 14-401, New York, NY 10032, USA.
Tolerogenic antigen presenting cells (APC) utilize inhibitory receptors ILT3 and ILT4. Engineered mutants reveal ILT3
Area of Science:
- Immunology
- Cell Biology
Background:
- Tolerogenic antigen presenting cells (APC) are crucial for immune homeostasis.
- High expression of inhibitory receptors ILT3 and ILT4 characterizes tolerogenic APCs.
Purpose of the Study:
- To investigate the extracellular signaling capacity of ILT3 and ILT4.
- To determine the role of the cytoplasmic regions of ILT3 and ILT4 in immune suppression.
Main Methods:
- Engineering of ILT3 and ILT4 cytoplasmic deletion mutants (ILT3delta and ILT4delta).
- Transfection of mutants into the dendritic-like cell line KG1.
- Assessment of T cell responses, including proliferation and cytotoxicity, and differentiation of CD8+ T regulatory cells.
Main Results:
- KG1.ILT3delta retained the inhibitory function of untruncated ILT3 on T cell proliferation and cytotoxicity.
- KG1.ILT4delta lost the suppressive activity of untruncated ILT4, indicating reliance on its cytoplasmic region.
- Recombinant soluble ILT3 inhibited T helper and cytotoxic functions and induced CD8+ T regulatory cell differentiation.
Conclusions:
- The inhibitory function of ILT4 is dependent on its cytoplasmic ITIM motifs.
- ILT3 can signal extracellularly to inhibit T cell responses and promote T regulatory cell generation.
- A feedback loop exists where T regulatory cells modulate APCs to induce inhibitory receptors, perpetuating immune tolerance.
More Related Videos
18:48In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients
Published on: August 12, 2017
07:55Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer
Published on: January 17, 2025